Tag: NeuroSense

Business

NeuroSense Therapeutics Information for Sale of 5.28 Million Widespread Shares to its Holders

NeuroSense Therapeutics Information for Sale of 5.28 Million Widespread Shares to its…

Gossip247 26/12/2024

Investment

NeuroSense Aligns With FDA On Section 3 Examine Of ALS Drug By Investing.com

CAMBRIDGE, Mass. – NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a micro-cap biotechnology firm…

Gossip247 11/12/2024

Please Enable JavaScript in your Browser to Visit this Site.

#mdp-ungrabber-js-disabled { position: fixed; top: 0; left: 0; height: 100%; width: 100%; z-index: 999999; text-align: center; background-color: #FFFFFF; color: #000000; font-size: 40px; display: flex; align-items: center; justify-content: center; }

Tag: NeuroSense

NeuroSense Therapeutics Information for Sale of 5.28 Million Widespread Shares to its Holders

NeuroSense Aligns With FDA On Section 3 Examine Of ALS Drug By Investing.com

About US

Quick Link

Top Categories

Subscribe to our newsletter